Sfoglia per Autore
Tumor Angiogenesis: A Target for Renal Cell Carcinoma Therapy.Current Perspectives and Novel Strategies
2012-01-01 Santoni, Matteo; Minardi, Daniele; Burattini, L.; Raquban, R.; Cascinu, Stefano; Muzzonigro, Giovanni
Pathogenic and Diagnostic Potential of BLCA-1 and BLCA-4 Nuclear Protein in Urothelial Cell Carcinoma of Human Bladder
2012-01-01 Santoni, Matteo; Catanzariti, F.; Minardi, Daniele; Burattini, L.; Nabissi, M.; Muzzonigro, G.; Cascinu, Stefano; Santoni, G.
Present and future of tyrosine kinase inhibitors in renal cell carcinoma: analysis of hematologic toxicity.
2012-01-01 Santoni, Matteo; Rizzo, M; Burattini, L; Farfariello, V; Berardi, Rossana; Santoni, G; Carteni, G; Cascinu, Stefano
Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study.
2012-01-01 Santoni, Matteo; A., Paccapelo; L., Burattini; Bianconi, Maristella; M., Cardinali; L., Fabbietti; R., Trignani; F., Rychlicki; Cascinu, Stefano
Urinary catheters and biofilm formation
2013-01-01 Minardi, Daniele; Conti, Alessandro; Santoni, Matteo; Cantoro, Daniele; Cirioni, Oscar; Ghiselli, Roberto; Silvestri, Carmela; Guerrieri, Mario; Giacometti, Andrea; Muzzonigro, Giovanni
Pazopanib and sunitinib trigger autophagic and non autophagic death of bladder tumor cells.
2013-01-01 Santoni, Matteo; Amantini, Consuelo; Beatrice Morelli, Maria; Liberati, Sonia; Farfariello, Valerio; Nabissi, Massimo; Laura, Bonfili; Maria Eleuteri, Anna; Mozzicafreddo, Matteo; Burattini, Luciano; Berardi, Rossana; Cascinu, Stefano; Santoni, Giorgio
VEGF expression and response to sunitinib in patients with metastatic clear cell renal cell carcinoma
2013-01-01 Minardi, Daniele; Lucarini, Guendalina; Santoni, Matteo; Mazzucchelli, Roberta; Burattini, Laura; Pistelli, M.; Bianconi, Maristella; DI PRIMIO, Roberto; Scartozzi, M.; Montironi, Rodolfo; Cascinu, Stefano; Muzzonigro, Giovanni
IMPACT OF VEGF, VEGFR, PDGFR, HIF AND ERCC1 GENE POLYMORPHISMS ON THYMIC MALIGNANCIES OUTCOME
2013-01-01 Berardi, R; Brunelli, A; Pagliaretta, S; Paolucci, V; Goteri, G; Refai, M; Pompili, C; Marcantognini, G; Morgese, F; Ballatore, Z; Savini, A; De Lisa, M; Caramanti, M; Santoni, M; Mazzanti, P; Onofri, A; Sabbatini, A; Cascinu, S.
Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma.
2013-01-01 Santoni, Matteo; Massari, F.; Amantini, C.; Nabissi, M.; Maines, F.; Burattini, L.; Berardi, Rossana; Santoni, G.; Montironi, Rodolfo; Tortora, G.; Cascinu, S.
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma
2014-01-01 Minardi, Daniele; Santoni, Matteo; Lucarini, Guendalina; Mazzucchelli, R; Burattini, L; Conti, Alessandro; Bianconi, Maristella; Scartozzi, M; DI PRIMIO, Roberto; Montironi, R; Cascinu, Stefano; Muzzonigro, G.
Role of natural and adaptive immunity in renal cell carcinoma response to VEGFR-TKIs and mTOR inhibitor.
2014-01-01 Santoni, Matteo; Berardi, Rossana; Amantini, C; Burattini, L; Santini, D; Santoni, G; Cascinu, S.
Selected news from the 2014 Genitourinary Cancers Symposium: Translating novel strategies into clinical practice
2014-01-01 Bianconi, Maristella; Santoni, Matteo; Massari, Francesco; Faloppi, Luca; Prete, Michela Del; Giampieri, Riccardo; Ciccarese, Chiara; Modena, Alessandra; Tortora, Giampalo; Scartozzi, Mario; Cascinu, Stefano
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma
2014-01-01 Andrikou, Kalliopi; Piva, Francesco; Santoni, Matteo; Conti, Alessandro; Mandolesi, Alessandra; Bittoni, Alessandro; Pellei, Chiara; Lanese, Andrea; Loretelli, Cristian; Scarpelli, Marina; Principato, Giovanni; Cascinu, Stefano
Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinoma
2014-01-01 Santoni, Matteo; Pantano, Francesco; Amantini, Consuelo; Nabissi, Massimo; Conti, Alessandro; Burattini, Luciano; Zoccoli, Alice; Berardi, Rossana; Santoni, Giorgio; Tonini, Giuseppe; Santini, Daniele; Cascinu, Stefano
Does prostate acinar adenocarcinoma with Gleason Score 3+3=6 have the potential to metastasize?
2014-01-01 Montironi, Rodolfo; Scarpelli, Marina; Mazzucchelli, Roberta; Lopez Beltran, A; Santoni, Matteo; Briganti, A; Montorsi, F; Cheng, L.
Renal cell carcinoma with rhabdoid features and loss of INI1 expression in an individual without sickle cell trait.
2014-01-01 Scarpelli, Marina; Mazzucchelli, Roberta; Lopez Beltran, A; Cheng, L; De Nictolis, M; Santoni, Matteo; Montironi, Rodolfo
Targeting prostate-specific membrane antigen for personalized therapies in prostate cancer: morphologic and molecular backgrounds and future promises.
2014-01-01 Santoni, Matteo; Scarpelli, Marina; Mazzucchelli, Roberta; Lopez Beltran, A; Cheng, L; Cascinu, S; Montironi, Rodolfo
Neuroendocrine differentiation in prostate cancer: novel morphological insights and future therapeutic perspectives.
2014-01-01 Santoni, Matteo; Conti, Alessandro; Burattini, L; Berardi, Rossana; Scarpelli, Marina; Cheng, L; Lopez Beltran, A; Cascinu, S; Montironi, Rodolfo
Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib
2014-01-01 Iacovelli, Roberto; Cartenì, Giacomo; Milella, Michele; Berardi, Rossana; Di Lorenzo, Giuseppe; Verzoni, Elena; Rizzo, Mimma; Santoni, Matteo; Procopio, Giuseppe
Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside.
2014-01-01 Santoni, Matteo; Santini, D.; Massari, F.; Conti, A.; Iacovelli, R.; Burattini, Laura; Tortora, G.; Falconi, Massimo; Montironi, Rodolfo; Cascinu, Stefano
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Tumor Angiogenesis: A Target for Renal Cell Carcinoma Therapy.Current Perspectives and Novel Strategies | 1-gen-2012 | Santoni, Matteo; Minardi, Daniele; Burattini, L.; Raquban, R.; Cascinu, Stefano; Muzzonigro, Giovanni | |
Pathogenic and Diagnostic Potential of BLCA-1 and BLCA-4 Nuclear Protein in Urothelial Cell Carcinoma of Human Bladder | 1-gen-2012 | Santoni, Matteo; Catanzariti, F.; Minardi, Daniele; Burattini, L.; Nabissi, M.; Muzzonigro, G.; Cascinu, Stefano; Santoni, G. | |
Present and future of tyrosine kinase inhibitors in renal cell carcinoma: analysis of hematologic toxicity. | 1-gen-2012 | Santoni, Matteo; Rizzo, M; Burattini, L; Farfariello, V; Berardi, Rossana; Santoni, G; Carteni, G; Cascinu, Stefano | |
Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study. | 1-gen-2012 | Santoni, Matteo; A., Paccapelo; L., Burattini; Bianconi, Maristella; M., Cardinali; L., Fabbietti; R., Trignani; F., Rychlicki; Cascinu, Stefano | |
Urinary catheters and biofilm formation | 1-gen-2013 | Minardi, Daniele; Conti, Alessandro; Santoni, Matteo; Cantoro, Daniele; Cirioni, Oscar; Ghiselli, Roberto; Silvestri, Carmela; Guerrieri, Mario; Giacometti, Andrea; Muzzonigro, Giovanni | |
Pazopanib and sunitinib trigger autophagic and non autophagic death of bladder tumor cells. | 1-gen-2013 | Santoni, Matteo; Amantini, Consuelo; Beatrice Morelli, Maria; Liberati, Sonia; Farfariello, Valerio; Nabissi, Massimo; Laura, Bonfili; Maria Eleuteri, Anna; Mozzicafreddo, Matteo; Burattini, Luciano; Berardi, Rossana; Cascinu, Stefano; Santoni, Giorgio | |
VEGF expression and response to sunitinib in patients with metastatic clear cell renal cell carcinoma | 1-gen-2013 | Minardi, Daniele; Lucarini, Guendalina; Santoni, Matteo; Mazzucchelli, Roberta; Burattini, Laura; Pistelli, M.; Bianconi, Maristella; DI PRIMIO, Roberto; Scartozzi, M.; Montironi, Rodolfo; Cascinu, Stefano; Muzzonigro, Giovanni | |
IMPACT OF VEGF, VEGFR, PDGFR, HIF AND ERCC1 GENE POLYMORPHISMS ON THYMIC MALIGNANCIES OUTCOME | 1-gen-2013 | Berardi, R; Brunelli, A; Pagliaretta, S; Paolucci, V; Goteri, G; Refai, M; Pompili, C; Marcantognini, G; Morgese, F; Ballatore, Z; Savini, A; De Lisa, M; Caramanti, M; Santoni, M; Mazzanti, P; Onofri, A; Sabbatini, A; Cascinu, S. | |
Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma. | 1-gen-2013 | Santoni, Matteo; Massari, F.; Amantini, C.; Nabissi, M.; Maines, F.; Burattini, L.; Berardi, Rossana; Santoni, G.; Montironi, Rodolfo; Tortora, G.; Cascinu, S. | |
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma | 1-gen-2014 | Minardi, Daniele; Santoni, Matteo; Lucarini, Guendalina; Mazzucchelli, R; Burattini, L; Conti, Alessandro; Bianconi, Maristella; Scartozzi, M; DI PRIMIO, Roberto; Montironi, R; Cascinu, Stefano; Muzzonigro, G. | |
Role of natural and adaptive immunity in renal cell carcinoma response to VEGFR-TKIs and mTOR inhibitor. | 1-gen-2014 | Santoni, Matteo; Berardi, Rossana; Amantini, C; Burattini, L; Santini, D; Santoni, G; Cascinu, S. | |
Selected news from the 2014 Genitourinary Cancers Symposium: Translating novel strategies into clinical practice | 1-gen-2014 | Bianconi, Maristella; Santoni, Matteo; Massari, Francesco; Faloppi, Luca; Prete, Michela Del; Giampieri, Riccardo; Ciccarese, Chiara; Modena, Alessandra; Tortora, Giampalo; Scartozzi, Mario; Cascinu, Stefano | |
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma | 1-gen-2014 | Andrikou, Kalliopi; Piva, Francesco; Santoni, Matteo; Conti, Alessandro; Mandolesi, Alessandra; Bittoni, Alessandro; Pellei, Chiara; Lanese, Andrea; Loretelli, Cristian; Scarpelli, Marina; Principato, Giovanni; Cascinu, Stefano | |
Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinoma | 1-gen-2014 | Santoni, Matteo; Pantano, Francesco; Amantini, Consuelo; Nabissi, Massimo; Conti, Alessandro; Burattini, Luciano; Zoccoli, Alice; Berardi, Rossana; Santoni, Giorgio; Tonini, Giuseppe; Santini, Daniele; Cascinu, Stefano | |
Does prostate acinar adenocarcinoma with Gleason Score 3+3=6 have the potential to metastasize? | 1-gen-2014 | Montironi, Rodolfo; Scarpelli, Marina; Mazzucchelli, Roberta; Lopez Beltran, A; Santoni, Matteo; Briganti, A; Montorsi, F; Cheng, L. | |
Renal cell carcinoma with rhabdoid features and loss of INI1 expression in an individual without sickle cell trait. | 1-gen-2014 | Scarpelli, Marina; Mazzucchelli, Roberta; Lopez Beltran, A; Cheng, L; De Nictolis, M; Santoni, Matteo; Montironi, Rodolfo | |
Targeting prostate-specific membrane antigen for personalized therapies in prostate cancer: morphologic and molecular backgrounds and future promises. | 1-gen-2014 | Santoni, Matteo; Scarpelli, Marina; Mazzucchelli, Roberta; Lopez Beltran, A; Cheng, L; Cascinu, S; Montironi, Rodolfo | |
Neuroendocrine differentiation in prostate cancer: novel morphological insights and future therapeutic perspectives. | 1-gen-2014 | Santoni, Matteo; Conti, Alessandro; Burattini, L; Berardi, Rossana; Scarpelli, Marina; Cheng, L; Lopez Beltran, A; Cascinu, S; Montironi, Rodolfo | |
Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib | 1-gen-2014 | Iacovelli, Roberto; Cartenì, Giacomo; Milella, Michele; Berardi, Rossana; Di Lorenzo, Giuseppe; Verzoni, Elena; Rizzo, Mimma; Santoni, Matteo; Procopio, Giuseppe | |
Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside. | 1-gen-2014 | Santoni, Matteo; Santini, D.; Massari, F.; Conti, A.; Iacovelli, R.; Burattini, Laura; Tortora, G.; Falconi, Massimo; Montironi, Rodolfo; Cascinu, Stefano |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile